Accessibility navigation


The impact of whey protein on plasma branched-chain amino acids and glycaemic control in humans. A narrative review

Bell, H., Jackson, K. ORCID: https://orcid.org/0000-0002-0070-3203, Crompton, L., Givens, I. ORCID: https://orcid.org/0000-0002-6754-6935 and Lovegrove, J. ORCID: https://orcid.org/0000-0001-7633-9455 (2025) The impact of whey protein on plasma branched-chain amino acids and glycaemic control in humans. A narrative review. Nutrition Research Reviews. ISSN 0954-4224 (In Press)

[thumbnail of Final_May2025_NRR_Accepted version.pdf] Text - Accepted Version
· Restricted to Repository staff only
· The Copyright of this document has not been checked yet. This may affect its availability.

426kB

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Abstract/Summary

Impaired glycaemic control is a major risk factor for developing type 2 diabetes (T2D), a worldwide health epidemic intrinsically linked to diet and obesity. Whey proteins (WP) are increasingly popular supplements that are a rich source of branched-chain amino acids (BCAA), essential for muscle protein synthesis and metabolic regulation. In humans, fasting plasma concentrations of BCAA are maintained around 350 µM but become chronically elevated by 10-25% in persons with T2D. Little is known about whether BCAA from WP impacts circulating BCAA concentrations and contributes to this phenomenon. This narrative review used a systematic search approach with relevant keywords to identify evidence from randomised controlled trials in normoglycaemic humans and those with insulin resistance or T2D, on the effects of WP intake on plasma BCAA and glycaemic control. This review is, to the authors’ knowledge, the first to specifically examine the effects of WP intake on plasma BCAA concentrations in relation to glycaemic control. Whilst the majority of acute studies identified (n=6) reported that WP consumption between 10 to 50 g significantly elevates postprandial BCAA and insulin responses (as evidenced by peak concentration and/or area under the curve), evidence from chronic studies (n=3) report inconsistent findings on the impact of 9 to 51g of WP per day on fasting BCAA and glycaemic control (e.g., fasting glucose and insulin, insulin clearance). Findings from this literature review highlight the need for further studies to investigate the relationship between WP consumption with BCAA and glycaemic control, and to determine underlying mechanisms of action.

Item Type:Article
Refereed:Yes
Divisions:Interdisciplinary centres and themes > Institute for Cardiovascular and Metabolic Research (ICMR)
Life Sciences > School of Agriculture, Policy and Development > Department of Animal Sciences
Interdisciplinary Research Centres (IDRCs) > Institute for Food, Nutrition and Health (IFNH)
Life Sciences > School of Chemistry, Food and Pharmacy > Department of Food and Nutritional Sciences > Human Nutrition Research Group
ID Code:123469
Publisher:Cambridge University Press

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation